Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | TGM2 | P21980 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.49 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.49 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 2/20 | 0.48 |
| ▸ | CA1 | P00915 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | CA9 | Q16790 | 2/20 | 0.48 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.47 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6051915 | 0.99 | HTT (0.56) | HTTMEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL4061201 | 0.92 | LMNA (0.65) | HTTMEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL3798700 | 0.90 | LMNA (0.63) | HTTMEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL14414733 | 0.88 | HTT (0.56) | HTTMEN1KMT2ALMNASMN1; SMN2 | |
| Zinc Ion SCHEMBL6912263 | 0.87 | HTT (0.54) | HTTMEN1KMT2ALMNASMN1; SMN2 | |
| Sulfuric Acid SCHEMBL6913701 | 0.87 | HTT (0.57) | HTTMEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL7514786 | 0.85 | HTT (0.73) | HTTMEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL4173649 | 0.83 | HTT (0.62) | HTTMEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL917878 | 0.83 | HTT (0.67) | HTTLMNASMN1; SMN2TGM2L3MBTL1 | |
| SCHEMBL3309927 | 0.83 | HTT (0.67) | HTTLMNASMN1; SMN2TGM2L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9655870-B2 | Homeopathic drug composition and methods of use thereof | FINDCURE.ORG (US) | 2017-05-23 | — | — | US | disclosed |
| US-9655870-B2 | Homeopathic drug composition and methods of use thereof | FINDCURE.ORG (US) | 2017-05-23 | — | — | US | disclosed |
| US-20070141169-A1 | Homeopathic drug composition and methods of use thereof | TAUB FLOYD | 2007-06-21 | — | — | US | disclosed |
| US-20070141169-A1 | Homeopathic drug composition and methods of use thereof | TAUB FLOYD | 2007-06-21 | — | — | US | disclosed |
| US-6762174-B1 | BETA-ALETHINE WITH MELPHALAN OR CYCLOPHOSPHAMIDE; PREVENTS CLINICAL APPEARANCE OF A NEOPLASTIC OR PRE-NEOPLASTIC CONDITION; IMMUNOMODULATION; ENHANCING CELL GROWTH, VITALITY, DIFFERENTIATION; ANTISENESCENCE | DOVETAIL TECHNOLOGIES, INC. | 2004-07-13 | — | — | US | disclosed |
| US-6498150-B2 | USEFUL IN ENHANCING VACCINATION, INCREASING SYNTHESIS AND FUNCTION OF BLOOD CELL COMPONENTS, AND ENHANCING ANTITUMOR EFFECTS | DOVETAIL TECHNOLOGIES, INC. | 2002-12-24 | — | — | US | disclosed |
| US-6451853-B1 | Small molecules that elicit a polarized Th1 response and for modulation of cellular immunity | DOVETAIL TECHNOLOGIES, INC | 2002-09-17 | — | — | US | disclosed |
| US-20020035118-A1 | LOW MOLECULAR WEIGHT CELL, BONE MARROW AND IMMUNE STIMULANTS | DOVETAIL TECHNOLOGIES INC. | 2002-03-21 | — | — | US | disclosed |
| US-6007819-A | Methods of inducing immunity using low molecular weight immune stimulants | DOVETAIL TECHNOLOGIES, INC. (US) | 1999-12-28 | — | — | US | disclosed |
| WO-1999042099-A1 | LOW MOLECULAR WEIGHT COMPOUNDS ADMINISTERED TOGETHER WITH ANTI-CANCER AGENTS TO TREAT CANCER AND PHARMACEUTICAL COMPOSITIONS THEREOF | DOVETAIL TECHNOLOGIES INC. (US) | 1999-08-26 | — | — | WO | disclosed |
| WO-1997014306-A1 | LOW MOLECULAR WEIGHT CELL, BONE MARROW AND IMMUNE STIMULANTS | DOVETAIL TECHNOLOGIES, INC. (US) | 1997-04-24 | — | — | WO | disclosed |
| US-5578313-A | Therapeutic use of vitaletheine modulators in neoplasia | THE UNIVERSITY OF NEW MEXICO (US) | 1996-11-26 | — | — | US | disclosed |
| US-4218404-A | HYPOGLYCEMIC AGENTS | CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT. (HU) | 1980-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020035118-A1 | LOW MOLECULAR WEIGHT CELL, BONE MARROW AND IMMUNE STIMULANTS | ACP1, CD14, HPGDS | HTT 4286/4885MEN1 982/4885KMT2A 2729/4885 |
| US-20070141169-A1 | Homeopathic drug composition and methods of use thereof | S100A11, PTGER3, CLN6 | HTT 46/4885MEN1 1894/4885KMT2A 3442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.